ESC Premium Access

Future direction for research in platelet P2Y12 iinhibition in acute coronary syndromes

Congress Presentation

About the speaker

Professor Kurt Huber

Sigmund Freud University Vienna, FacutlVice Dean of Researchy fo Medicine, Vienna (Austria)
54 presentations

4 more presentations in this session

State of the art in platelet P2Y12 iinhibition in acute coronary syndromes

Speaker: Professor J. Collet (Paris, FR)


Greater efficacy of prasugrel and ticagrelor administered at first medical contact compared to a switching strategy during the first hours after primary percutaneous coronary intervention

Speaker: Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)


Chewing versus traditional swallowing of ticagrelor to accelerate platelet inhibition in acute coronary syndrome- the CHEERS study

Speaker: Doctor E. Asher (Jerusalem, IL)


Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials

Speaker: Doctor A. Eisen (Petah Tikva, IL)


Access the full session

Rapid platelet P2Y12 iinhibition in acute coronary syndromes

Speakers: Professor K. Huber, Professor J. Collet, Doctor A. Marcano Fernandez, Doctor E. Asher, Doctor A. Eisen

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb